Insiders Ocugen, Inc.

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-08 EDT			5-day change	1st Jan Change
1.72 ^USD	+9.55%		+23.74%	+199.13%

04-29	Ocugen, Inc. Announces Ocu400 Modifier Gene Therapy Phase 1/2 Data Presentation At Retinal Cell and Gene Therapy Innovation Summit 2024	CI
04-22	Chardan Adjusts Price Target on Ocugen to $5 From $4, Maintains Buy Rating	MT

Ocugen, Inc. Announces Ramesh Kumar Will Not Stand for Re-Election as Director	03-20	CI
Ocugen, Inc. Appoints Huma Qamar as Chief Medical Officer	03-18	CI
Ocugen, Inc. Announces Bob Smith Joins Business Advisory Board	01-16	CI
Ocugen, Inc. Appoints Connie Collingsworth to the Business Advisory Board	23-09-21	CI
Ocugen, Inc. Announces Executive Changes	23-09-19	CI
Ocugen, Inc. Announces Executive Changes	23-08-15	CI
Ocugen, Inc. Announces Resignation of Quan Vu as Chief Financial Officer	23-08-15	CI
Ocugen, Inc. Announces Business Advisory Board	23-06-05	CI
Ocugen, Inc. Announces Executive Changes	23-03-10	CI
Ocugen, Inc. Appoints Quan A. Vu to Chief Business Officer	23-03-06	CI
Ocugen Appoints Quan Vu as Finance Chief	23-03-06	MT
Ocugen, Inc. Appoints Quan A. Vu as Chief Financial Officer	23-03-06	CI
Insider Sell: Ocugen	23-02-17	MT
Ocugen, Inc. Appoints Quan A. Vu as Chief Business Officer	23-02-01	CI
Insider Sell: Ocugen	23-01-19	MT
Insider Sell: Ocugen	22-12-20	MT
Insider Sell: Ocugen	22-10-14	MT
Ocugen, Inc. Announces Board Changes	22-09-01	CI
Insider Sell: Ocugen	22-07-15	MT
Ocugen Named Among Philadelphia’s ‘2022 Best Places to Work’	22-06-14	AQ

No results for this search